What Is Dilated Cardiomyopathy?
Dilated cardiomyopathy, known as DCM, is a disease of the heart muscle rather than the valves. In dogs with DCM, the walls of the ventricles — the heart's main pumping chambers — become thin and weakened, causing the chambers to dilate and lose their ability to contract effectively. The result is a heart that is physically larger but functionally impaired, unable to push sufficient blood around the body with each beat.
DCM is the second most common form of heart disease in dogs overall, but in large and giant breeds it is the most prevalent cardiac condition encountered. Unlike mitral valve disease, which tends to progress slowly over many years, DCM can advance rapidly and may cause sudden death even before obvious symptoms have appeared.
Which Breeds Are Most at Risk?
DCM shows a very strong breed predisposition, and in some cases a clear genetic basis has been identified. The breeds most commonly affected include:
- Dobermann Pinscher — the breed most severely affected, with studies suggesting up to 58% of Dobermanns develop DCM
- Great Dane
- Irish Wolfhound
- Boxer
- Cocker Spaniel (both American and English)
- Dalmatian
- Portuguese Water Dog
- Newfoundland
- Saint Bernard
In Boxers, a related condition called arrhythmogenic right ventricular cardiomyopathy is sometimes classified separately, as it primarily affects the right side of the heart and frequently causes arrhythmias rather than straightforward chamber dilation.
The Grain-Free Diet Controversy
From around 2018, the US Food and Drug Administration began investigating a potential link between grain-free diets high in legumes — particularly those featuring peas, lentils, and chickpeas as primary ingredients — and an apparent increase in DCM cases in breeds not traditionally predisposed to the condition. Golden Retrievers featured prominently in these reports.
The relationship between diet and DCM remains an active area of research and genuine scientific debate. Some cases appeared to resolve when dogs were switched from grain-free to traditional grain-containing diets, which has led many cardiologists to advise caution around high-legume formulations until more is understood. However, a definitive causal mechanism has not been established, and the topic remains nuanced. If you are feeding a grain-free or boutique diet, it is worth discussing the current evidence with your vet.
How DCM Develops
DCM typically passes through two distinct phases. The first is an occult or preclinical phase during which the heart is already structurally abnormal, but the dog shows no outward signs of illness. This phase can last for months to years. During this time, dangerous heart rhythm abnormalities — arrhythmias — may occur, and sudden cardiac death can happen even in dogs that appear completely well.
The second phase is overt DCM, when the dog begins to display clinical signs of heart failure. By the time symptoms are apparent, the disease is often already advanced.
Symptoms to Watch For
Because DCM can progress silently, knowing what to look for is critically important, particularly if you own an at-risk breed. Signs may include:
- Rapid or laboured breathing, including an increased resting respiratory rate
- Coughing, though this is less consistent in DCM than in mitral valve disease
- Exercise intolerance and sudden profound fatigue
- Weakness or collapse, sometimes occurring during or after physical activity
- Fainting episodes
- Abdominal distension caused by fluid accumulation
- Pale or bluish gums
- Sudden loss of appetite and weight loss
Collapse and sudden death are particularly associated with DCM because arrhythmias — abnormal heart rhythms — are a prominent feature of the condition, especially in Dobermanns. These rhythm disturbances can trigger ventricular fibrillation, which is life-threatening without immediate intervention.
Early Detection Through Screening
Given the occult phase of DCM and the risk of sudden death, proactive cardiac screening is arguably more important for DCM-prone breeds than for any other group. The Dobermann is perhaps the clearest example: breed clubs and cardiologists widely recommend annual cardiac screening from the age of three or four years, combining echocardiography with a Holter monitor recording.
A Holter monitor is a portable ECG device worn by the dog continuously for 24 hours. It captures the total number and pattern of abnormal heartbeats over that period, which a single clinic-based ECG cannot reliably do. In Dobermanns, a threshold of more than 50 ventricular premature contractions in 24 hours is generally considered significant and warrants further evaluation and possible treatment.
Echocardiography looks for chamber dilation and reduced contractility before symptoms appear. Both tests are important and neither fully substitutes for the other.
Diagnosis and Investigation
In dogs presenting with symptoms, or in those picked up through screening, investigation typically involves:
- Echocardiogram to assess chamber size and systolic function
- 24-hour Holter monitoring to characterise rhythm disturbances
- Chest radiography to evaluate cardiac silhouette size and lung changes
- Blood tests including cardiac biomarkers such as NT-proBNP and cardiac troponin I, which can indicate myocardial stress and injury
Cardiac biomarkers are an increasingly valuable screening tool. Elevated NT-proBNP in an apparently healthy Dobermann, for example, is a strong indicator that further assessment with echocardiography is warranted.
Treatment and Management
There is no cure for DCM, but treatment can improve quality of life and extend survival. Pimobendan has been shown to delay the onset of heart failure in Dobermanns identified in the occult phase with echocardiographic evidence of DCM — a finding from the PROTECT study published in 2012.
Once heart failure develops, management mirrors that used for advanced mitral valve disease: diuretics to manage fluid accumulation, ACE inhibitors, and continued pimobendan. Anti-arrhythmic medications such as sotalol or mexiletine may be added specifically to address rhythm disturbances.
Prognosis for DCM is generally more guarded than for MMVD, with survival after heart failure onset often measured in months. However, with vigilant monitoring and appropriate treatment, some dogs do considerably better than average, particularly when the condition is caught early through screening.
The Importance of Breed-Specific Awareness
If you own a breed on the at-risk list, I cannot overstate the value of building a relationship with a veterinary cardiologist and committing to regular screening. The occult phase represents a window during which intervention may delay progression. Waiting for symptoms is a strategy that, in DCM, carries real and serious risk.